http://bmj.com/cgi/content/full/323/7323/1206

 

BMJ 2001;323:1206 ( 24 November )

News roundup

Deaths trigger fresh controversy over vitamin A programme in India

Ganapati Mudur New Delhi

Indian doctors have renewed their accusation that international agencies are needlessly promoting the administration of vitamin A across India to all children aged below 5 years.

Paediatricians and nutritionists launched a barrage of criticism after 14 children died and thousands fell ill last week in the north eastern state of Assam following a vitamin A campaign supported by Unicef. Health officials are investigating the deaths and illness amid suspicions that health workers might have given overdoses to children during the state-wide campaign to deliver vitamin A to three million children aged 1 to 5 years.

Unicef had replaced the traditional 2 millilitre spoons with 5 millilitre cups to pour out vitamin A for the campaign. Health officials suspect that this switch in the method of measuring the vitamin and the inadequate training of health workers might have led to overdoses, but they have not ruled out contamination or other causes. Unicef officials in New Delhi said that the cups had been introduced because they were considered more efficient and hygienic. They said the cups were now being withdrawn, but they added that it was unlikely that overdoses had caused the deaths and illness. "Even a full 5 millilitre cup of vitamin A would not be lethal," a Unicef official said.

Some Indian doctors have questioned the benefits and safety of the administration of vitamin A through the "pulse campaign" promoted by Unicef. The campaign involves delivering the supplement to all children aged 1 to 5 years across a state on a single day. The Indian health ministry has had a vitamin A programme running for more than three decades that covers children aged 9 months to 3 years and is linked to immunisation. However, less than 30% of target children in India receive even one dose of vitamin A.

Paediatricians are urging more selective use of vitamin A because child nutrition has improved and clinical signs of vitamin A deficiency, such as symptoms of eye disease, are becoming less common. However, Unicef maintains that symptoms of eye disease are associated with advanced vitamin A deficiency and that children might be needlessly put at risk of impaired immune function and fatal infections long before such symptoms appear.

Paediatricians reject that argument. "There is no clinching evidence to show reduction in mortality through vitamin A among children with subclinical vitamin A deficiency," said Dr Harsh Pal Singh Sachdev, professor of paediatrics and clinical epidemiology at the Maulana Azad Medical College, New Delhi, and editor of the journal Indian Pediatrics.

A technical consultation initiated by the health ministry last year concluded that existing data were not sufficiently robust to recommend vitamin A supplementation to reduce mortality in children aged 1 to 5 years. "The promotion of the universal distribution of vitamin A is a glaring example of the commercial exploitation of malnutrition in developing countries by pharmaceutical companies," said Dr Umesh Kapil, additional professor of human nutrition, All India Institute of Medical Sciences, New Delhi.

The Nutrition Society of India has warned that the Assam episode will lead to an erosion of public confidence in government healthcare programmes and might even cause a serious setback to the pulse poliomyelitis campaign.
 

Abridged text of this article

PDF [abridged] of this article

Email this article to a friend

Send a response to this article

Electronic responses to this article

Download to Citation Manager

Search Medline for articles by:
Mudur, G.

Alert me when:
New articles cite this article

Rapid Response responses to this article:

Read all Rapid Response responses

Over dose of Vitamin A and possible hypercalcemia

Padmanabhan Badrinath, Clinical Assistant Professor & Hon Consultant in Preventive Medicine , Department of Community Medicine, UAE University, PO Box 17666, Al-Ain, UAE

bmj.com, 22 Nov 2001 [Response]

Where did it go wrong?

Dr. Lalitha D'Souza, Researcher , National Perinatal Epidemiology Unit, Institute of Health Sciences, University of Oxford, Oxford OX3

bmj.com, 23 Nov 2001 [Response]

Administration of Massive dose of Vitamin A and related deaths in India

Dr. Umesh Kapil, Additional Professor , All India indsititue of Medical Sciences,New Delhi, India

bmj.com, 23 Nov 2001 [Response]

No short cuts in Public Health!!!

Dinesh Agarwal

bmj.com, 23 Nov 2001 [Response]


ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.